Alveo Technologies and Global Animal Health Partner to De...
Tech Beetle briefing GB

Alveo Technologies and Global Animal Health Partner to Deploy National-Scale Molecular Avian Influenza Surveillance Across Egypt

Essential brief

Alveo Technologies and Global Animal Health Partner to Deploy National-Scale Molecular Avian Influenza Surveillance Across Egypt

Key facts

Alveo Technologies and Global Animal Health have launched Egypt's first national-scale, on-site molecular surveillance for avian influenza in poultry.
The program uses real-time molecular diagnostics to provide rapid, accurate detection directly at poultry farms, reducing delays in outbreak response.
This deployment is a pilot with plans to expand molecular avian influenza surveillance across the Middle East region.
The initiative demonstrates the growing role of molecular diagnostics in veterinary health and biosecurity, supporting early detection and control of infectious diseases.
By improving disease monitoring, the partnership aims to protect poultry health, support farmers, and reduce economic impacts from avian influenza.

Highlights

Alveo Technologies and Global Animal Health have launched Egypt's first national-scale, on-site molecular surveillance for avian influenza in poultry.
The program uses real-time molecular diagnostics to provide rapid, accurate detection directly at poultry farms, reducing delays in outbreak response.
This deployment is a pilot with plans to expand molecular avian influenza surveillance across the Middle East region.
The initiative demonstrates the growing role of molecular diagnostics in veterinary health and biosecurity, supporting early detection and control of infectious diseases.

Alveo Technologies, recognized for its advanced molecular sensing and diagnostic capabilities, has teamed up with Global Animal Health to launch a groundbreaking national-scale surveillance program for avian influenza in Egypt.

This initiative marks the first large-scale deployment of on-site, real-time molecular diagnostic technology specifically designed for poultry disease monitoring.

By integrating Alveo's proprietary molecular detection systems, the program aims to enhance early detection and control of avian influenza outbreaks, which pose significant risks to both animal health and the poultry industry.

The surveillance network utilizes rapid molecular assays that can be conducted directly at poultry farms, enabling immediate results without the delays associated with traditional laboratory testing.

This approach not only accelerates response times but also improves the accuracy and reliability of disease monitoring.

The deployment in Egypt serves as a pilot for broader regional expansion, with plans to extend similar surveillance capabilities across the Middle East.

This collaboration underscores the growing importance of molecular diagnostics in veterinary health and biosecurity, offering a scalable model for managing infectious diseases in livestock.

By leveraging cutting-edge technology, the partnership aims to safeguard poultry populations, support farmers, and mitigate economic losses caused by avian influenza.

The initiative also highlights the potential for molecular diagnostics to revolutionize disease surveillance beyond human health applications, emphasizing a One Health perspective that integrates animal and environmental health considerations.

As avian influenza continues to threaten global food security, such innovative surveillance strategies are critical for timely intervention and prevention measures.